# Dapagliflozin in Mangement of Pulmonary Hypertension Patients

> **NCT06612086** · PHASE1 · NOT_YET_RECRUITING · sponsor: **Assiut University** · enrollment: 70 (estimated)

## Conditions studied

- Pulmonary Hypertension

## Interventions

- **DRUG:** Dapagliflozin (Forxiga)

## Key facts

- **NCT ID:** NCT06612086
- **Lead sponsor:** Assiut University
- **Sponsor class:** OTHER
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** NOT_YET_RECRUITING
- **Start date:** 2024-10-25
- **Primary completion:** 2025-09-10
- **Final completion:** 2026-10-10
- **Target enrollment:** 70 (ESTIMATED)
- **Last updated:** 2024-10-29


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06612086

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06612086, "Dapagliflozin in Mangement of Pulmonary Hypertension Patients". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06612086. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*